211 related articles for article (PubMed ID: 21221198)
1. Perindopril: the evidence of its therapeutic impact in hypertension.
Thomson A; Greenacre M
Core Evid; 2007 Mar; 2(1):63-79. PubMed ID: 21221198
[TBL] [Abstract][Full Text] [Related]
2. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
Dahlöf B; Sever PS; Poulter NR; Wedel H; Beevers DG; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J;
Lancet; 2005 Sep 10-16; 366(9489):895-906. PubMed ID: 16154016
[TBL] [Abstract][Full Text] [Related]
3. Adherence to Treatment, Safety, Tolerance, and Effectiveness of Perindopril/Amlodipine Fixed-Dose Combination in Greek Patients with Hypertension and Stable Coronary Artery Disease: A Pan-Hellenic Prospective Observational Study of Daily Clinical Practice.
Liakos CI; Papadopoulos DP; Kotsis VT
Am J Cardiovasc Drugs; 2017 Oct; 17(5):391-398. PubMed ID: 28466368
[TBL] [Abstract][Full Text] [Related]
4. Optimizing the treatment of hypertension and stable coronary artery disease: clinical evidence for fixed-combination perindopril/amlodipine.
Ferrari R
Curr Med Res Opin; 2008 Dec; 24(12):3543-57. PubMed ID: 19032136
[TBL] [Abstract][Full Text] [Related]
5. Perindopril for the treatment of hypertension.
Ghiadoni L
Expert Opin Pharmacother; 2011 Jul; 12(10):1633-42. PubMed ID: 21599567
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
Brugts JJ; Ferrari R; Simoons ML
Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
[TBL] [Abstract][Full Text] [Related]
7. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
Dolan E; Stanton AV; Thom S; Caulfield M; Atkins N; McInnes G; Collier D; Dicker P; O'Brien E;
J Hypertens; 2009 Apr; 27(4):876-85. PubMed ID: 19516185
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.
Ferrari R
Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572
[TBL] [Abstract][Full Text] [Related]
9. A review of Perindopril in the reduction of cardiovascular events.
Campbell DJ
Vasc Health Risk Manag; 2006; 2(2):117-24. PubMed ID: 17319455
[TBL] [Abstract][Full Text] [Related]
10. Specific properties and effect of perindopril in controlling the renin-angiotensin system.
Ferrari R; Pasanisi G; Notarstefano P; Campo G; Gardini E; Ceconi C
Am J Hypertens; 2005 Sep; 18(9 Pt 2):142S-154S. PubMed ID: 16125051
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibition in hypertension: focus on perindopril.
Cockcroft JR
Am J Cardiovasc Drugs; 2007; 7(5):303-17. PubMed ID: 17953470
[TBL] [Abstract][Full Text] [Related]
12. Perindopril for control of blood pressure in patients with hypertension and other cardiovascular risk factors: an open-label, observational, multicentre, general practice-based study.
Ogilvie RI; Anand S; Roy P; De Souza S;
Clin Drug Investig; 2008; 28(11):673-86. PubMed ID: 18840010
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Fixed-Dose Perindopril/Amlodipine on Clinic, Ambulatory and Self-Monitored Blood Pressure and Blood Pressure Variability: An Open-Label, Non Comparative Study in the General Practice.
Karpov YA; Gorbunov VM; Deev AD
High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):417-25. PubMed ID: 26351011
[TBL] [Abstract][Full Text] [Related]
14. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
PROGRESS Collaborative Group
Lancet; 2001 Sep; 358(9287):1033-41. PubMed ID: 11589932
[TBL] [Abstract][Full Text] [Related]
15. Which patients benefit the most from the perindopril/amlodipine combination.
Mourad JJ
J Hypertens; 2011 Dec; 29 Suppl 1():S23-8. PubMed ID: 22157564
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
Kim S; Zhan Y; Izumi Y; Iwao H
Hypertension; 2000 Mar; 35(3):769-74. PubMed ID: 10720593
[TBL] [Abstract][Full Text] [Related]
17. Perindopril: an updated review of its use in hypertension.
Hurst M; Jarvis B
Drugs; 2001; 61(6):867-96. PubMed ID: 11398915
[TBL] [Abstract][Full Text] [Related]
18. A new dimension in hypertension management with the amlodipine/perindopril combination.
Poulter NR
J Hypertens; 2011 Dec; 29 Suppl 1():S15-21. PubMed ID: 22157563
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive efficacy of perindopril 5-10 mg/day in primary health care: an open-label, prospective, observational study.
Ionescu DD;
Clin Drug Investig; 2009; 29(12):767-76. PubMed ID: 19888783
[TBL] [Abstract][Full Text] [Related]
20. Evidence for benefits of perindopril in hypertension and its complications.
Laurent S
Am J Hypertens; 2005 Sep; 18(9 Pt 2):155S-162S. PubMed ID: 16125052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
